Search Results - "MURRAY, Bernard P"
-
1
Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat
Published in Kidney international (01-08-2014)“…Many xenobiotics including the pharmacoenhancer cobicistat increase serum creatinine by inhibiting its renal active tubular secretion without affecting the…”
Get more information
Journal Article -
2
Key Metabolic Enzymes Involved in Remdesivir Activation in Human Lung Cells
Published in Antimicrobial agents and chemotherapy (17-08-2021)“…Remdesivir (RDV; GS-5734, Veklury), the first FDA-approved antiviral to treat COVID-19, is a single-diastereomer monophosphoramidate prodrug of an adenosine…”
Get full text
Journal Article -
3
Regional proteomic quantification of clinically relevant non-cytochrome P450 enzymes along the human small intestine
Published in Drug metabolism and disposition (01-07-2020)“…Current challenges in accurately predicting intestinal metabolism arise from the complex nature of the intestine, leading to limited applicability of available…”
Get full text
Journal Article -
4
Cobicistat (GS-9350): A Potent and Selective Inhibitor of Human CYP3A as a Novel Pharmacoenhancer
Published in ACS medicinal chemistry letters (12-08-2010)“…Cobicistat (3, GS-9350) is a newly discovered, potent, and selective inhibitor of human cytochrome P450 3A (CYP3A) enzymes. In contrast to ritonavir, 3 is…”
Get full text
Journal Article -
5
Preclinical Characterization of GS-9669, a Thumb Site II Inhibitor of the Hepatitis C Virus NS5B Polymerase
Published in Antimicrobial Agents and Chemotherapy (01-02-2013)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
6
Characterization of the mechanism of action of lanraplenib, a novel spleen tyrosine kinase inhibitor, in models of lupus nephritis
Published in BMC rheumatology (30-03-2021)“…B cells are critical mediators of systemic lupus erythematosus (SLE) and lupus nephritis (LN), and antinuclear antibodies can be found in the serum of…”
Get full text
Journal Article -
7
In Vitro Characterization of GS-8374, a Novel Phosphonate-Containing Inhibitor of HIV-1 Protease with a Favorable Resistance Profile
Published in Antimicrobial Agents and Chemotherapy (01-04-2011)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
8
Structure–activity relationships of diamine inhibitors of cytochrome P450 (CYP) 3A as novel pharmacoenhancers, part I: Core region
Published in Bioorganic & medicinal chemistry letters (01-02-2014)“…The synthesis and evaluation of analogs with extensive modifications of the 1,4-diamine core along with the structure activity relationships with respect to…”
Get full text
Journal Article -
9
Assessing Pleiotropic Effects of a Mixed-Mode Perpetrator Drug, Rifampicin, by Multiple Endogenous Biomarkers in Dogs
Published in Drug metabolism and disposition (14-02-2024)“…Rifampicin (RIF) is a mixed-mode perpetrator that produces pleiotropic effects on liver cytochrome P450 enzymes and drug transporters. To assess the complex…”
Get full text
Journal Article -
10
Comparison of Tissue Abundance of Non-Cytochrome P450 Drug-Metabolizing Enzymes by Quantitative Proteomics between Humans and Laboratory Animal Species
Published in Drug metabolism and disposition (01-03-2022)“…The use of animal pharmacokinetic models as surrogates for humans relies on the assumption that the drug disposition mechanisms are similar between preclinical…”
Get full text
Journal Article -
11
Lenacapavir Exhibits Atropisomerism-Mechanistic Pharmacokinetics and Disposition Studies of Lenacapavir Reveal Intestinal Excretion as a Major Clearance Pathway
Published in The Journal of pharmacology and experimental therapeutics (18-09-2024)“…Lenacapavir (LEN), a long-acting injectable, is the first approved human immunodeficiency virus type 1 capsid inhibitor and one of a few Food and Drug…”
Get more information
Journal Article -
12
Identification and characterization of erlotinib as a potent mechanism-based inactivator of human aldehyde oxidase
Published in Drug metabolism and pharmacokinetics (01-04-2024)Get full text
Journal Article -
13
Dissecting Parameters Contributing to the Underprediction of Aldehyde Oxidase-Mediated Metabolic Clearance of Drugs
Published in Drug metabolism and disposition (01-10-2023)“…We investigated the effect of variability and instability in aldehyde oxidase (AO) content and activity on the scaling of in vitro metabolism data. AO content…”
Get full text
Journal Article -
14
Ontogeny of Human Liver Aldehyde Oxidase: Developmental Changes and Implications for Drug Metabolism
Published in Molecular pharmaceutics (08-05-2024)“…Despite the increasing importance of aldehyde oxidase (AO) in the drug metabolism of clinical candidates, ontogeny data for AO are limited. The objective of…”
Get full text
Journal Article -
15
Pharmacokinetics and Disposition of Momelotinib Revealed a Disproportionate Human Metabolite-Resolution for Clinical Development
Published in Drug metabolism and disposition (01-03-2018)“…Momelotinib (MMB), a small-molecule inhibitor of Janus kinase (JAK)1/2 and of activin A receptor type 1 (ACVR1), is in clinical development for the treatment…”
Get full text
Journal Article -
16
Vacuolar degradation of rat liver CYP2B1 in Saccharomyces cerevisiae: further validation of the yeast model and structural implications for the degradation of mammalian endoplasmic reticulum P450 proteins
Published in Molecular pharmacology (01-05-2005)“…Mammalian hepatic cytochromes P450 (P450s) are endoplasmic reticulum (ER)-anchored hemoproteins with highly variable half-lives. CYP3A4, the dominant human…”
Get more information
Journal Article -
17
Effects of GS-9876, a novel spleen tyrosine kinase inhibitor, on platelet function and systemic hemostasis
Published in Thrombosis research (01-10-2018)“…Spleen tyrosine kinase (SYK) mediates signal transduction in multiple hematopoietic cells, including platelets. SYK signals downstream of immunoreceptors and…”
Get full text
Journal Article -
18
The Drug–Drug Interaction Profile of Presatovir
Published in Journal of clinical pharmacology (01-06-2018)“…Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infections in young children. Presatovir (previously GS‐5806) is a novel, orally…”
Get full text
Journal Article -
19
Discovery of GS-9669, a Thumb Site II Non-Nucleoside Inhibitor of NS5B for the Treatment of Genotype 1 Chronic Hepatitis C Infection
Published in Journal of medicinal chemistry (13-03-2014)“…Investigation of thiophene-2-carboxylic acid HCV NS5B site II inhibitors, guided by measurement of cell culture medium binding, revealed the structure–activity…”
Get full text
Journal Article -
20
Native CYP2C11: heterologous expression in Saccharomyces cerevisiae reveals a role for vacuolar proteases rather than the proteasome system in the degradation of this endoplasmic reticulum protein
Published in Molecular pharmacology (01-05-2002)“…Cytochromes P450 (P450s) are hemoprotein enzymes committed to the metabolism of chemically diverse endo- and xenobiotics. They are anchored to the endoplasmic…”
Get more information
Journal Article